28.71
+1.97(+7.37%)
Currency In USD
| Previous Close | 26.74 |
| Open | 26.39 |
| Day High | 28.94 |
| Day Low | 26.35 |
| 52-Week High | 35.25 |
| 52-Week Low | 13.53 |
| Volume | 1.75M |
| Average Volume | 2.49M |
| Market Cap | 2.91B |
| PE | -6.51 |
| EPS | -4.41 |
| Moving Average 50 Days | 24.63 |
| Moving Average 200 Days | 21.09 |
| Change | 1.97 |
If you invested $1000 in Beam Therapeutics Inc. (BEAM) since IPO date, it would be worth $1,531.2 as of December 04, 2025 at a share price of $28.71. Whereas If you bought $1000 worth of Beam Therapeutics Inc. (BEAM) shares 3 years ago, it would be worth $647.06 as of December 04, 2025 at a share price of $28.71.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
GlobeNewswire Inc.
Nov 12, 2025 12:00 PM GMT
CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat duri
Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
GlobeNewswire Inc.
Nov 03, 2025 2:00 PM GMT
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficac
Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences
GlobeNewswire Inc.
Aug 25, 2025 11:00 AM GMT
CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in fireside chats at th